GleamWall
中文EN

NRC NRC HEALTH

Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 70487 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.4%
TTM net income YoY-60.6%
TTM EPS YoY6,909.9%
Revenue 3-yr CAGR-1.1%
Net income 3-yr CAGR-39.3%

Margins

Gross margin—
Operating margin11.1%
Net margin4.5%
FCF margin12.8%
EBITDA margin17.0%

Returns

ROE248.1%
ROA4.7%
ROIC (approx.)10.9%
Asset turnover1.05x

Leverage & solvency

Liabilities / assets106.6%
Debt / equity—
Current ratio0.64x
Interest coverage2.91x

Cash quality & payout

Operating cash flow / net income3.69x
Accruals ratio-12.6%
Payout ratio209.2%
Capex / revenue3.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2025*2025-12-31FY2024*2024-12-31
Income statement
Revenue$137.39M$143.06M
SG&A expense$54.80M$44.91M
Operating income$22.59M$35.19M
Interest expense$4.76M$2.60M
Pretax income$17.84M$32.69M
Income tax$6.25M$7.91M
Net income$11.60M$24.78M
EBITDA$30.21M$41.22M
EPS (basic)50.001.05
EPS (diluted)50.001.04
Dividends declared per share0.520.48
Weighted avg. shares (diluted)22.40M23.74M
Balance sheet
Cash & equivalents$4.14M$4.23M
Receivables$11.11M$11.05M
Current assets$20.21M$19.60M
PP&E, net$40.47M$38.27M
Goodwill$66.15M$66.15M
Intangibles$2.23M$2.62M
Total assets$134.88M$132.54M
Current liabilities$36.62M$35.86M
Short-term debt$4.01M—
Long-term debt$75.02M$57.90M
Total debt$79.03M$57.90M
Total liabilities$120.89M$101.25M
Shareholders' equity$13.99M$31.28M
Net debt$74.90M$53.66M
Shares outstanding22.64M23.08M
Cash flow statement
Operating cash flow$26.45M$34.62M
Capital expenditure$10.71M$15.45M
Free cash flow$15.74M$19.18M
Investing cash flow-$10.71M-$20.28M
Financing cash flow-$15.84M-$16.76M
Depreciation & amortization$7.62M$6.02M
Stock-based compensation$3.31M$284,000
Dividends paid$10.98M$11.45M
Share buybacks$20.18M$30.95M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.